IRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc., (NYSE:AGN) today announced that the company has received approval from the U.S. Food and Drug Administration (FDA) to market JUVÉDERM VOLUMA™ XC, the ...
JUVÉDERM® VOLUX™ XC IS THE FIRST AND ONLY HYALURONIC ACID (HA) FILLER TO RECEIVE U.S. FDA APPROVAL FOR IMPROVING JAWLINE DEFINITION IRVINE, Calif., Aug. 3, 2022 /PRNewswire/ -- Today, Allergan ...
One of the few downsides to dermal fillers such as Juvederm, Restylane,Radiesse, and Sculptra can be temporary bruising around the area of the injection that can last upwards of 14-21 days. According ...
Actual patient treated with JUVÉDERM® VOLUX® XC in the jawline and JUVÉDERM® VOLUMA® XC in the cheeks and chin. Results may vary. Advancements in aesthetic procedures have enabled us to achieve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results